Katharina A. Ponto

The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy

Luigi Bartalena, George J. Kahaly, L. Baldeschi et al. · European Journal of Endocrinology · 2021 · 977 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

A Novel Thyroid Stimulating Immunoglobulin Bioassay Is a Functional Indicator of Activity and Severity of Graves’ Orbitopathy

Simon D. Lytton, Katharina A. Ponto, Michael Kanitz et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 216 citations · Full text

Life Sciences, Endocrinology, Molecular Biology +14

Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial

George J. Kahaly, Michaela Riedl, J. König et al. · The Lancet Diabetes & Endocrinology · 2018 · 216 citations

Pharmacy, Endocrinology, Pharmacotherapy +9

Myopia and Level of Education

Alireza Mirshahi, Katharina A. Ponto, René Hoehn et al. · Ophthalmology · 2014 · 181 citations

Health Professions, Ophthalmology, Optometry +8

Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment

Raymond S. Douglas, George J. Kahaly, Shoaib Ugradar et al. · Ophthalmology · 2021 · 158 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +13